In studies involving ovarian cancer cell lines (SKOV3, ES2, RMG1) and a murine ovarian cancer model, ONA inhibited cancer cell proliferation by suppressing STAT3 activation, a pathway crucial to cancer progression and chemoresistance. This evidence concerns the gene STAT3 and ovarian cancer.